Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Comparison of Combined ACB and IPACK Versus ACB Alone for Postoperative Pain Management After ACL Reconstruction

18. November 2026 aktualisiert von: Kazi Mahzabin Arin, Bangladesh Medical University

Evaluation of Combined Adductor Canal Block and Infiltration Between the Popliteal Artery and Capsule of the Knee (IPACK) Block Versus Adductor Canal Block (ACB) Alone on Postoperative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction-A Randomized Controlled Trial

This randomized controlled trial aims to evaluate whether combining an adductor canal block (ACB) with an infiltration between the popliteal artery and the knee capsule (IPACK) provides better postoperative analgesia than ACB alone in patients undergoing anterior cruciate ligament reconstruction.

A total of 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II will be randomly allocated into two groups. The intervention group will receive ultrasound-guided combined ACB and IPACK blocks, while the comparator group will receive ultrasound-guided ACB alone. Both groups will receive spinal anesthesia and standardized postoperative analgesia.

Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS) at 2, 6, 12, and 24 hours after surgery. Other outcomes will include total opioid consumption during the first 24 hours, postoperative quality of recovery assessed by the QoR-15 questionnaire, time to first rescue analgesic request, maximum walking distance, and block-related complications.

The findings are expected to provide evidence on the effectiveness of adding an IPACK block to ACB to improve postoperative pain management following ACL reconstruction.

Studienübersicht

Detaillierte Beschreibung

Anterior cruciate ligament reconstruction (ACLR) is a commonly performed orthopedic procedure for patients with anterior cruciate ligament injuries. Despite its minimally invasive arthroscopic approach, the procedure is frequently associated with significant postoperative pain due to surgical tissue injury, graft harvesting, tourniquet application, and postoperative inflammatory responses. Inadequate pain management may interfere with early mobilization, delay rehabilitation, increase opioid consumption, and negatively affect postoperative recovery.

Effective postoperative analgesia is therefore an important component of perioperative care following anterior cruciate ligament (ACL) reconstruction. Multimodal analgesia, including regional anesthesia techniques, is increasingly used to improve pain control while minimizing opioid-related adverse effects.

The adductor canal block (ACB) is an ultrasound-guided regional anesthesia technique that primarily targets the saphenous nerve and provides analgesia to the anterior and medial aspects of the knee while generally preserving quadriceps muscle strength. However, adductor canal block (ACB) alone may provide inadequate analgesia for pain originating from the posterior aspect of the knee.

The infiltration between the popliteal artery and the knee capsule (IPACK) block is an ultrasound-guided regional anesthesia technique designed to provide analgesia to the posterior knee capsule while minimizing motor blockade. Combining infiltration between the popliteal artery and the knee capsule (IPACK) with adductor canal block (ACB) may provide more comprehensive postoperative analgesia by addressing both anterior-medial and posterior knee pain.

The present randomized controlled trial is designed to evaluate the effectiveness of combined ultrasound-guided adductor canal block (ACB) and infiltration between the popliteal artery and the knee capsule (IPACK) blocks compared with ultrasound-guided adductor canal block (ACB) alone in patients undergoing arthroscopic anterior cruciate ligament reconstruction.

The study will include 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II who are scheduled for anterior cruciate ligament (ACL) reconstruction. Participants will be recruited using consecutive sampling and randomly allocated 1:1 to two study groups using computer-generated block randomization. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. The outcome assessor will remain blinded to the group allocation.

Participants allocated to this group will receive an ultrasound-guided adductor canal block with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided IPACK block with an additional 20 mL of 0.25% bupivacaine.

Participants allocated to this group will receive ultrasound-guided adductor canal block alone using 20 mL of 0.25% bupivacaine.

Both groups will undergo surgery under standard spinal anesthesia. Standardized postoperative analgesia will be provided using intravenous paracetamol (15 mg/kg) every 8 hours. Rescue analgesia with intravenous morphine (3 mg) will be administered when the postoperative Numeric Rating Scale (NRS) pain score exceeds 5, with repeat administration if required.

The study findings will help determine whether adding an IPACK block to an adductor canal block provides improved postoperative analgesia compared with ACB alone following ACL reconstruction.

Studientyp

Interventionell

Einschreibung (Geschätzt)

72

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

      • Dhaka, Bangladesch, 1000
        • Bangladesh Medical University
        • Kontakt:
        • Hauptermittler:
          • Mosharof Hossain, MD

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 50 Jahre (Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Patient with anterior cruciate ligament injury requiring surgery.
  • Adult patients
  • Patients aged between 18 and 50 years
  • BMI
  • Patients of either sex.
  • American Society of Anesthesiologists (ASA) physical status I-II.

Exclusion Criteria:

  • Known allergy to local anesthetic drugs
  • Coagulopathy or patients receiving anticoagulant therapy
  • Infection at the site of injection
  • Chronic opioid use or opioid dependence
  • Pregnancy

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Group IPACK+ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided infiltration between the popliteal artery and the knee capsule (IPACK) using an additional 20 mL of 0.25% bupivacaine. Both blocks will be administered before surgery. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Participants will receive an ultrasound-guided combined adductor canal block (ACB) and an infiltration between the popliteal artery and the knee capsule (IPACK) before surgery. The ACB will be performed using 20 mL of 0.25% bupivacaine administered around the saphenous nerve in the adductor canal. The IPACK block will be performed using an additional 20 mL of 0.25% bupivacaine injected into the interspace between the popliteal artery and the posterior capsule of the knee under ultrasound guidance. Both blocks will be administered as a combined regional anesthesia technique for postoperative pain management following anterior cruciate ligament reconstruction.

Aktiver Komparator: Group ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) alone using 20 mL of 0.25% bupivacaine before surgery. No IPACK block will be administered. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Ultrasound-guided adductor canal block will be performed with the participant in the supine position. A linear ultrasound transducer will be placed over the mid-thigh to identify the femoral artery and adjacent saphenous nerve beneath the sartorius muscle. After confirming needle placement and careful aspiration, 20 mL of 0.25% bupivacaine will be injected around the saphenous nerve in 5 mL increments.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative Pain Intensity Measured by Numeric Rating Scale (NRS)
Zeitfenster: 2, 6, 12, and 24 hours after surgery

Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain), both at rest and during movement (knee flexion greater than 45 degrees). Pain scores will be recorded and compared between the two study groups.

2, 6, 12, and 24 hours after surgery

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Time to First Analgesic Request
Zeitfenster: First 24 hours after surgery

The time from the end of surgery to the first request for postoperative rescue analgesia will be recorded in hours and compared between the two study groups.

First 24 hours after surgery
Postoperative Quality of Recovery Measured by QoR-15 Score
Zeitfenster: 24 hours after surgery

Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better recovery quality. Scores will be compared between the two study groups.

24 hours after surgery
Adverse Effects
Zeitfenster: Up to 24 hours following surgery

Incidence of Block-Related Adverse Effects

Up to 24 hours following surgery
Total Opioid Consumption During the First 24 Hours After Surgery
Zeitfenster: First 24 hours after surgery

Measure and compare the total opioid consumption between the two study groups during the first 24 hours after surgery. Opioid consumption will be recorded and expressed in morphine-equivalent doses (mg).

First 24 hours after surgery

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Dezember 2026

Primärer Abschluss (Geschätzt)

31. Mai 2027

Studienabschluss (Geschätzt)

31. Mai 2027

Studienanmeldedaten

Zuerst eingereicht

12. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

18. November 2026

Zuerst gepostet (Tatsächlich)

20. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

20. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

18. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Studiendaten/Dokumente

  1. Studienprotokoll
    Informationskennung: pain.medicine@bmu.ac.bd

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren